Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VOTRIENT for Soft tissue cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where VOTRIENT was used for Soft tissue cancer.

Most Reported Side Effects for VOTRIENT

Side Effect Reports % Deaths Hosp.
Death 167 27.6% 167 8
Hypertension 65 10.7% 5 28
Nausea 59 9.7% 9 29
Diarrhoea 54 8.9% 4 21
Fatigue 52 8.6% 10 21
Vomiting 44 7.3% 6 26
Decreased appetite 40 6.6% 6 20
Investigation 40 6.6% 0 39
Disease progression 38 6.3% 24 11
Asthenia 37 6.1% 6 19
Malaise 22 3.6% 3 11
Abdominal pain 20 3.3% 2 8
Hair colour changes 20 3.3% 0 7
Platelet count decreased 20 3.3% 1 7
Blood pressure increased 18 3.0% 2 10

Other Indications for VOTRIENT

Renal cancer (111) Renal cell carcinoma (105) Product used for unknown indication (97) Sarcoma (24) Renal cancer metastatic (22) Leiomyosarcoma (21) Metastatic renal cell carcinoma (21) Neoplasm malignant (21) Soft tissue sarcoma (16) Angiosarcoma (12)

Other Drugs Used for Soft tissue cancer

GLEEVEC (7)

Related Pages

VOTRIENT Full Profile All Soft tissue cancer Drugs VOTRIENT Demographics VOTRIENT Timeline